Jane Mitchell

Jane Mitchell is Head of the Vascular Biology research group at NHLI. Professor Mitchell is a stream lead for the taught MSc course: Genes, Drugs and Stem Cells.

Professor Mitchell completed a PhD in Pharmacology with Sir Professor John R Vane (FRS, Nobel Laureate) and Dr Gilberto De Nucci 1990 before joining Professor Ferid Murad (NAS USA, Nobel Laureate) as a fellow of Northwestern University (Chicago, USA) for her postdoctoral training in the biochemistry of nitric oxide synthase. She returned to work with John Vane on the pharmacology of cyclo-oxygenase isoforms before joining the group of Professor Timothy Williams at the National Heart and Lung Institute, now part of Imperial College.

Professor Mitchell was awarded a Wellcome Trust Career Development Fellowship in 1997 and the Novartis Prize for Pharmacology in 1999 for her contribution to the field of cyclo-oxygeanse biology. Since this time, Professor Mitchell has led her own group - Cardiothoracic Pharmacology - consisting of academics, clinicians, postdoctoral fellows and undergraduate/postgraduate students.

Professor Mitchell is amongst the top 1% of cited pharmacologists world-wide and as such, is a member of Thomson Scientific Highlycited listings (isihighlycited.com) with more than 150 publications in peer reviewed journals.

Professor Mitchell was awarded the 2009 Rector’s Award for Excellence in Research Supervision and Elected Research Supervision Fellow.

Professor Mitchell was awarded the AstraZeneca Women in Pharmacology Prize in 2012.

Selecterd Publications

Journals

Raman L, Stewart I, Barrett S, et al., 2022, Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study, European Respiratory Journal, Vol:9, ISSN:0903-1936, Pages:1-12

George PM, Reed A, Desai SR, et al., 2022, A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae., Science Translational Medicine, Vol:14, ISSN:1946-6234, Pages:1-16

Raman L, Stewart I, Barratt S, et al., 2022, Nintedanib for progressive pulmonary fibrosis: 12-month outcome data from a multicentre observational study, SPRINGER LONDON LTD, Pages:S139-S139, ISSN:0021-1265

Pires ML, Ferreira P, Shala F, et al., 2022, Using Renal-Specific Cyclo-Oxygenase-2-Deficient Mice to Understand the Pro-Thrombotic Effects of Non-Steroidal Anti-Inflammatory Drugs, Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, LIPPINCOTT WILLIAMS & WILKINS, ISSN:0009-7322

Pires ML, Vinokurova M, Shala F, et al., 2022, Identifying Sources of Prostacyclin Outside the Vascular Wall and Their Contribution to Cardiovascular Protection, Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, LIPPINCOTT WILLIAMS & WILKINS, ISSN:0009-7322